The prognostic significance of tumour infiltrating lymphocytes in oral squamous cell carcinoma.

local recurrence-free survival overall survival prognostic factor tumour infiltrating lymphocytes (TILs) oral squamous cell carcinoma

Journal

Polish journal of pathology : official journal of the Polish Society of Pathologists
ISSN: 1233-9687
Titre abrégé: Pol J Pathol
Pays: Poland
ID NLM: 9437432

Informations de publication

Date de publication:
2019
Historique:
entrez: 10 3 2020
pubmed: 1 1 2019
medline: 3 4 2020
Statut: ppublish

Résumé

Currently there is being conducted an extensive search to find new prognostic factors in oral squamous cell carcinoma which would assist in better patient management. One of the most promising prognostic markers is the density of tumour infiltrating lymphocytes. 100 cases of patients with oral squamous cell carcinoma that underwent surgical resection between 2006 and June 2016 at our institution were included in this study. From each case the most representative HE stained slide was identified and the density of tumour infiltrating lymphocytes were classified as non-brisk or brisk, which was included in the survival analysis. Upon analysis there was a strong correlation between non-brisk (n = 28) and brisk (n = 72) tumour infiltrating lymphocytes and the primary clinical outcomes: overall survival (p = 0.0472) and local recurrence-free survival (p = 0.00037). Univariate and multivariate Cox regression model confirmed the high prognostic value of tumour infiltrating lymphocytes as the independent prognostic indicator of better survival, being even superior, in our study, to the traditional pTNM system. This study provides robust evidence that the density of tumour infiltrating lymphocytes demonstrates a high prognostic significance in oral squamous cell carcinoma.

Identifiants

pubmed: 32146797
pii: 39927
doi: 10.5114/pjp.2019.93130
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-285

Auteurs

Mariusz Książek (M)

Department of Pathology, MedLifeCover, Krosno, Poland.

Bogumił Lewandowski (B)

Department of Oral and Maxillofacial Surgery, Clinical Voivodeship Hospital Nr 1, Rzeszow, Poland.
Department of Emergency Medical Service, Faculty of Medicine, the University of Rzeszow, Poland.

Robert Brodowski (R)

Department of Oral and Maxillofacial Surgery, Clinical Voivodeship Hospital Nr 1, Rzeszow, Poland.

Paweł Pakla (P)

Department of Oral and Maxillofacial Surgery, Clinical Voivodeship Hospital Nr 1, Rzeszow, Poland.

Marta Kawalec-Książek (M)

Intensive Care Unit and Anaesthesia with Acute Poisons Centre, Clinical Voivodeship Hospital Nr 2, Rzeszow, Poland.

Ludmiła Fudali (L)

retired from Department of Pathology, Clinical Voivodeship Hospital Nr 1, Rzeszow, Poland.

Janusz Ryś (J)

Department of Tumour Pathology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Krakow Branch, Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH